137 related articles for article (PubMed ID: 28418844)
1. Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.
Petersen LF; Klimowicz AC; Otsuka S; Elegbede AA; Petrillo SK; Williamson T; Williamson CT; Konno M; Lees-Miller SP; Hao D; Morris D; Magliocco AM; Bebb DG
Oncotarget; 2017 Jun; 8(24):38326-38336. PubMed ID: 28418844
[TBL] [Abstract][Full Text] [Related]
2. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.
Feng X; Li H; Dean M; Wilson HE; Kornaga E; Enwere EK; Tang P; Paterson A; Lees-Miller SP; Magliocco AM; Bebb G
Breast Cancer Res; 2015 May; 17(1):65. PubMed ID: 25935535
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of DNA Repair Protein Expression in Non-Small Cell Lung Cancers Treated with Platinum-Based Chemotherapy and Subsequent Curative Lung Resection.
Shin J; Lee KS; Yoh KA; Cho HJ; Choi MK; Kim SH; Kim YJ; Chung JH; Cho S; Kim K; Jheon S; Yoon HI; Lee JH; Lee CT; Lee JS
Oncology; 2018; 95(1):20-30. PubMed ID: 29694959
[TBL] [Abstract][Full Text] [Related]
5. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
Otsuka S; Klimowicz AC; Kopciuk K; Petrillo SK; Konno M; Hao D; Muzik H; Stolte E; Boland W; Morris D; Magliocco AM; Bebb DG
J Thorac Oncol; 2011 Jul; 6(7):1169-78. PubMed ID: 21623238
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.
Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ
Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938
[TBL] [Abstract][Full Text] [Related]
9. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
[TBL] [Abstract][Full Text] [Related]
10. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
12. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
[TBL] [Abstract][Full Text] [Related]
13. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
[TBL] [Abstract][Full Text] [Related]
15. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
Fung AS; Kopciuk K; Dean ML; D'Silva A; Otsuka S; Klimowicz A; Hao D; Morris D; Bebb DG
PLoS One; 2021; 16(1):e0241240. PubMed ID: 33507926
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
18. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
[TBL] [Abstract][Full Text] [Related]
20. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
Kamphues C; Bova R; Bahra M; Klauschen F; Muckenhuber A; Sinn BV; Warth A; Goeppert B; Endris V; Neuhaus P; Weichert W; Stenzinger A
Pancreas; 2015 Mar; 44(2):296-301. PubMed ID: 25423555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
